Life sciences startup Cora Therapeutics raises C$1m in seed VC

Based in Toronto, Cora Therapeutics is the developer of DNA HALO, an advanced antioxidant formulation.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this